Category: PMCPA Case of the Week

Cases selected for the AskAnzal weekly PMCPA insight newsletter

8 Mar 2026

AUTH/2548/11/12: Anonymous NHS health professionals v Baxter (ISU Belfast meeting sponsorship and β€˜luxurious venue’ perception)

Baxter UK was ruled in breach of Clause 9.1 after exhibiting at a Northern Ireland urology meeting held…

8 Mar 2026

AUTH/2681/11/13: Hospital doctor v GlaxoSmithKline (invitation strapline β€˜do more, feel better, live longer’) – no breach on appeal

A hospital doctor said GSK’s β€˜do more, feel better, live longer’ strapline on a BTS stand invitation implied…

8 Mar 2026

AUTH/2728/8/14: Anonymous prescriber complaint about Relvar Ellipta pneumonia risk messaging (No breach)

Anonymous prescriber alleged GSK hid asthma pneumonia risk in Relvar promotion and cherry-picked COPD comparisons. PMCPA Panel found…

8 Mar 2026

Janssen voluntary admission: Crohn’s β€œdisease awareness” campaign ruled pre-licence promotion for ustekinumab (AUTH/2871/8/16)

Janssen admitted a Crohn’s awareness campaign sent to UK gastroenterologists promoted ustekinumab for an unlicensed indication and was…

8 Mar 2026

Anonymous v Pfizer and Novartis (AUTH/2928/1/17 & AUTH/2929/1/17): Ultibro promotion, PV concerns and breach of undertaking

PV consultant alleged off-label exacerbation-risk promotion for Ultibro. Panel found breaches for a FLAME β€œbusiness card” and unclear…

8 Mar 2026

AUTH/2045/9/07: Lilly v Novo Nordisk – Levemir advertorial in Pulse and β€œweight advantages” claim

Lilly challenged a Levemir advertorial in Pulse. PMCPA found the β€œWeight advantages with Levemir” section misleading/ambiguous and inconsistent…

8 Mar 2026

AUTH/1884/8/06: Hospital Chief Pharmacist v Servier (Protelos) – representative conduct, call frequency and inducements

Servier rep’s proactive call rate exceeded Code limits and biscuits/snacks were used to gain access. Panel found breaches…

8 Mar 2026

AUTH/1854/6/06: Servier – Coversyl journal ad alleged to breach an undertaking (no breach)

A pharmacist alleged Servier reused a Coversyl ad previously ruled misleading. The Panel found the ad had been…

8 Mar 2026

AUTH/1909/11/06: Medical Representative v AstraZeneca (Arrangements for meetings) – No breach

A medical representative alleged AstraZeneca meetings were visible to the public and that surgery meetings were fund-raising with…

8 Mar 2026

Tillotts v Ferring: Cortiment leavepiece not withdrawn and misleading β€œgeneric budesonides” claim (AUTH/3143/1/19)

Ferring agreed in inter-company dialogue to withdraw a Cortiment leavepiece but it was still used at a conference…

⭐ Flagship Programme

AQP Flagship Path — the complete UK ABPI signatory programme

12 modules. 12 weeks. Final Signatory readiness. The industry standard for ABPI Code signatories — £995 + VAT.

Enrol — AQP Path Learn more

📰 Weekly PMCPA Case Breakdown

One real case. One key lesson. Every week β€” free.

Subscribe Free
🎓 AQP Training